In vitro detecting ultra-trace novalgin in medicine and human urine by chemiluminescence.
A sensitive chemilumimetric method for the determination of novalgin at the sub-nanogram level is presented. The method is based on immobilized luminol and dichromate chemiluminescence detection coupled with a flow injection system. The intensity of the chemiluminescence can be strongly inhibited by novalgin and the decrement of CL intensity was linear with the logarithm of novalgin concentration in the range of 5.0x10(-11) to 5.0x10(-8) gml(-1). The detection limit is 2.0x10(-11) gml(-1) (3sigma) and the relative standard deviation is 2.57% (n=5) for a 1.0x10(-10) gml(-1) novalgin sample. A typical analytical procedure, including sampling and washing, could be performed in 1 min at a flow rate of 2.0 mlmin(-1), giving a throughput of 60 h(-1). The proposed procedure was applied successfully in pharmaceutical preparations and furthermore the monitoring of novalgin in human urine without any pre-treatment process during 10 h. It was found that the novalgin concentration reached its maximum after orally administrated for about 4 h, and the novalgin metabolism ratio in 10 h was 10.83% in the body of volunteers. The flow system offered reagentless procedures and remarkable stability in determination of novalgin, and could be easily reused over 600 times.